Whitehawk Therapeutics (AADI) Q4 2023 Earnings

13MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.72
-0.67
-0.62
-0.57

Details

Expected EPS
-0.65
Actual EPS
-0.6
Surprise EPS
0.05
Surprise Percent
+7.69%

Description

Whitehawk Therapeutics (AADI) has reported earnings of -0.6 per share for Q4 2023.

0 Comments

Share your thoughts